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Abstract
Background: Independent genome-wide association studies (GWAS) showed an obesogenic effect of two single nucleotide
polymorphisms (SNP; rs12970134 and rs17782313) more than 150 kb downstream of the melanocortin 4 receptor gene
(MC4R). It is unclear if the SNPs directly influence MC4R function or expression, or if the SNPs are on a haplotype that
predisposes to obesity or includes functionally relevant genetic variation (synthetic association). As both exist, functionally
relevant mutations and polymorphisms in the MC4R coding region and a robust association downstream of the gene, MC4R
is an ideal model to explore synthetic association.
Methodology/Principal Findings: We analyzed a genomic region (364.9 kb) encompassing the MC4R in GWAS data of 424
obesity trios (extremely obese child/adolescent and both parents). SNP rs12970134 showed the lowest p-value (p=0.004;
relative risk for the obesity effect allele: 1.37); conditional analyses on this SNP revealed that 7 of 78 analyzed SNPs provided
independent signals (p#0.05). These 8 SNPs were used to derive two-marker haplotypes. The three best (according to p-
value) haplotype combinations were chosen for confirmation in 363 independent obesity trios. The confirmed obesity effect
haplotype includes SNPs 39 and 59 of the MC4R. Including MC4R coding variants in a joint model had almost no impact on
the effect size estimators expected under synthetic association.
Conclusions/Significance: A haplotype reaching from a region 59 of the MC4R to a region at least 150 kb from the 39 end of
the gene showed a stronger association to obesity than single SNPs. Synthetic association analyses revealed that MC4R
coding variants had almost no impact on the association signal. Carriers of the haplotype should be enriched for relevant
mutations outside the MC4R coding region and could thus be used for re-sequencing approaches. Our data also underscore
the problems underlying the identification of relevant mutations depicted by GWAS derived SNPs.
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Introduction
Alleles of common single nucleotide polymorphisms (SNPs)
rs12970134 and rs17782313 located downstream of the MC4R
(154 kb and 188 kb, respectively) were shown to be associated with
obesity and related traits [1,2].
SNP rs17782313 had been identified in a large-scale interna-
tional cooperation encompassing more than 90,000 individuals [1].
Initially, GWAS data obtained in seven studies (16,876 Europeans)
had been meta-analyzed. The second strongest association signal
mapped 188 kb downstream of the MC4R. This location of
rs17782313 indicates that its relevance for weight regulation might
be mediated via effects on MC4R expression. The association result
was confirmed in independent samples of a total of 60,352 adults
and 5,988 children. Amongst the adults, each copy of the
rs17782313 effect (C) allele was associated with a change in BMI
of ,0.22 kg/m
2. A copy of the allele resulted in an odds ratio of
1.08 and 1.12 for overweight and obesity, respectively [1].
This small effect size was confirmed by three subsequent GWAS
meta-analyses for human obesity genes [3–5]. All of these GWAS
picked up rs17782313 as a polygenic variant for obesity; a total of
more than 150,000 individuals was analyzed [2,4–7].
Additionally, a GWAS for insulin resistance and related
phenotypes in 2,684 Indian Asians (including subsequent analyses
in 11,955 individuals of Indian Asian or European ancestry)
detected an association of rs12970134 located 154 kb downstream
PLoS ONE | www.plosone.org 1 November 2010 | Volume 5 | Issue 11 | e13967of MC4R with waist circumference (p=1.7610
29). The effect was
also present in normal weight individuals. Hence, it was suggested
that the association of rs12970134 with insulin resistance is
partially independent of obesity [2]. Association of rs12970134
with BMI was also found in the whole study group (N=11,955;
p=6.4610
25; 0.25 kg/m
2, 95% CI 0.13–0.38 kg/m
2); in the
4,561 Europeans alone the effect size was similar (0.28 kg/m
2,
95% CI 0.05–0.51 kg/m
2).
Currently, it is unclear if and how the association signals of the
two common non-coding GWAS-derived SNPs (rs17782313 and
rs12970134, with pairwise linkage disequilibrium of D9=0.92 and
r
2=0.75 according to Ensembl version 57; CEU; Genome
Assembly GRCh37) 154 and 188 kb of the 39 end of the MC4R
relate to the receptor gene.
On the other hand, approximately 130 mutations have been
detected in the human MC4R gene; those leading to a reduced
function result in a dominantly inherited form of obesity [8]. 2–6%
of extremely obese children and adolescents harbour such
mutations. Most of these lead to a total or partial loss of function
as shown by in vitro assays [9]. Quantitative trait analyses in
pedigrees revealed that individuals with these mutations had a
significantly higher current BMI (4.5 and 9.5 kg/m
2 in males and
females, respectively) than their relatives without the mutations
[10]. Phenotypical effects of MC4R mutations other than obesity
have been shown to encompass hyperinsulinemia, elevated growth
rates and higher bone density [11].
In addition to these rare mutations, the minor alleles of two
MC4R non-synonymous polymorphisms (Val103Ile, Ile251Leu)
have convincingly been shown to be protective against obesity
[12–16]. Heterozygotes for the 103Ile variant of Val103Ile were
found in 2–9% of subjects in different populations. An effect size
estimate of 20.48 kg/m
2 for Ile103 carriers was calculated [12]
and subsequently confirmed in an extended single large epidemi-
ological study of approximately 8,000 individuals [13]. Additional
meta-analyses encompassing a total of 53,343 individuals again
confirmed the initial finding [15,16]. In a GWAS with a focus on
early-onset extreme obesity, candidate genes for obesity had
specifically been tested. The negative association with obesity for
the 103Ile variant of Val103Ile was again supported (p=4.2610
24
[5]). In the GWAS detecting the association of obesity with the 39
MC4R-SNP [1], the respective finding could not be explained by
the two non-synonymous polymorphisms (Val103Ile, Ile251Leu).
This conclusion was based on both imputed data with a high
confidence score for Val103Ile (posterior probability .0.99 using
IMPUTE) and on directly genotyped data for both polymorphisms
on a subsample of the study group (Val103Ile, n=5,516 and
Ile251Leu: n=5,039) [1]. Functional studies showed that the
MC4R-103Ile reveals a modest, but significant decrease in
antagonist potency [17]. The effect of potent endogenous pro-
opiomelanocortin-derived agonists at the MC4R seemed to be
increased for MC4R-103Ile [17]. Hence, both the lower
antagonistic and the increased agonistic potencies are compatible
with an elevated MC4R function, which could explain the weight-
reducing effect of the variant.
Finally, a consistent negative association of the Leu251 variant
with body weight (minor allele frequency approx. 1 percent) of the
second non-synonymous coding polymorphism (Ile251Leu;
rs52820871) was detected in about 17,000 individuals of European
origin. The effect was shown for extremely obese children and
adults (odds ratios ranging from 0.25 to 0.76) and within
population-based samples. A meta-analysis supported the evidence
of the obesity-protective effect of MC4R Leu251 (odds ra-
tio=0.52) [14]. An increased basal activity was described for the
Leu251 variant [17].
We deem the MC4R coding region and the distant SNPs as an
excellent example for the recently proposed synthetic association
[18,19]. Accordingly, GWAS signals of common non-functional
SNPs outside of coding regions may be the result of a combination
of rare coding/functional variants with stronger effects given that
these rare variants arose on a haplotype which is tagged by the
common SNP. Here we investigate synthetic association by
analyzing if common genetic variation (SNPs and haplotypes
thereof) genotyped in the non-coding genomic region of the MC4R
locus is related to coding (functional) variants of the MC4R. In the
first step, we analyzed the genomic region covering both 39 SNPs
(rs17782313 and rs12970134), the MC4R and SNPs in its 59
flanking region to extract all evidence for common variation
related to obesity at the MC4R locus. Transmission disequilibrium
was analyzed in GWAS data (78 SNPs) of 424 obesity trios.
Conditioning on the strongest single-marker signal in our sample,
we screened the remaining 77 SNPs for independent (secondary
signals with a p-value#0.05 in the conditional test) signals.
Subsequently, we determined the transmission patterns of all
possible two-marker haplotypes of the primary and the indepen-
dent signals. We searched for over-transmission of ‘obesity
haplotypes’ to determine if the distant non-coding 39 SNPs
(rs17782313 and rs12970134) belong to haplotypes which extend
into the MC4R locus. In the second step, we incorporated
information on mutations and polymorphisms within the MC4R
coding region to analyze if synthetic association explains the
GWAS signals of the distant SNPs.
Results
Extended family-based haplotype analyses of common
variants
We analyzed 78 SNPs in the genomic region comprising the
MC4R gene and reaching from the recombination hotspot at
55,879.013 bps (recombination rate: 43.3 cM/Mb), 310.5 kb 39 of
the MC4R, to the recombination hotspot at 56,243,921 bps
(recombination rate: 89.5 cM/Mb) 52.9 kb 59 of the MC4R
coding region. Analyses were performed in 424 extremely obese
German children and adolescents and both of their parents
(Affymetrix Genome-Wide Human SNP Array 6.0). The strongest
single-marker association signal (according to nominal p-values in
the genomic region) was observed for rs12970134 (two-sided exact
p=0.004, relative risk (RR)=1.37, 95% confidence interval (CI):
1.11–1.69) which had previously been reported by Chambers et al.
[2]. SNP rs12970134 was in moderate to strong linkage
disequilibrium (LD) to the other previously reported GWAS
SNP rs17782313 [1] with D9=0.931 and r
2=0.770 (thus, our
data were similar to the Ensembl 57 data base entry). A search for
secondary signals when conditioning on the strongest signal
(rs12970134) revealed that 7 additional SNPs provided indepen-
dent signals (p#0.05). Expectedly, rs17782313 did not provide an
independent contribution compared to rs12970134 due to the
aforementioned LD. The total of 8 SNPs with independent
contributions was used to derive the three best two-marker
haplotype combinations according to their p-value in the
haplotype transmission disequilibrium test (Figure 1).
For replication, all 4 SNPs (rs17700028, rs12970134, rs1943226
and rs1943229) involved in the three best haplotype combinations
(p#0.05 after Bonferroni correction for the 28 haplotypic tests
performed) were genotyped in 363 independent obesity trios
(Table 1). For one haplotype combination, Haplo 1 (rs17700028
and rs12970134), the haplotype TDT was nominally significant
(p#0.05) in the detection as well as in the replication sample.
However, the corresponding risk haplotype [G; A] of Haplo 1 is
MC4R: Synthetic Association?
PLoS ONE | www.plosone.org 2 November 2010 | Volume 5 | Issue 11 | e13967rare (estimated frequency in the joint sample of 787 par-
ents<0.2%) and does not provide evidence for an association in
the joint sample (haplotype RR (hRR)=3.24 with 95% CI: 0.36–
29.12, p-value=0.29). Analysis of the full set of 787 obesity trios
showed a higher hRR for the risk haplotype combination Haplo 3
than for any other single marker or haplotype combination
(Tables 1 and 2). Interestingly, Haplo 3 covers the MC4R
(Figure 1). In more detail, the combination of the risk alleles of
the SNPs included in Haplo 3 resulted in a hRR for [A; G]=1.61,
(95% CI: 1.30–2.00) for obesity, which was descriptively stronger
than the relative risks for each of the single markers effect alleles
(rs12970134; A is obesity effect allele: RR=1.33, 95% CI: 1.14–
1.55; rs1943229; G is obesity effect allele: RR=1.03, 95% CI:
0.86–1.23). Note that the single-marker association signal for
rs1943229 resulted in p-value=0.86 in the joint sample (Table 2).
Synthetic association – assessment of the relationship of
MC4R coding variants to common obesity-associated
SNPs outside of the MC4R coding region
As both, common distant SNPs and functionally relevant low
frequency genetic variation within MC4R, are associated with
obesity, the MC4R might be an example for ‘synthetic association’.
Accordingly, we evaluated the impact of MC4R coding variants on
the association signals of the distant SNPs or their respective two-
marker haplotype. First, we explored the impact of the non-
synonymous polymorphisms Val103Ile and Ile251Leu. Secondly,
we assessed the impact of mutations in the MC4R coding region
that lead to a reduced receptor function.
The obesity effect alleles of the non-synonymous polymorphisms
Val103Ile and Ile251Leu (the wild-type alleles G and T) were
frequently detected on the common obesity haplotype comprising
the obesity effect alleles at rs12970134 and rs1943229 (Table 3;
left panel). As expected, pairwise LD measures between the two
non-synonymous MC4R polymorphisms and the two SNPs of the
obesity haplotype are larger for D9 (range 0.475–1), whereas the
respective r
2 values were low (range 0.001–0.007) due to the low
allele frequencies of these polymorphisms.
We observed a slightly stronger transmission disequilibrium of
the obesity haplotype [A; G] of Haplo 3 (transmission-ratio=1.56;
Table 3) if it included the wild-type, ‘obesogenic’ alleles of the two
non-synonymous MC4R polymorphisms as compared to the
situation of an un-stratified assessment of omitting the two
polymorphisms (transmission-ratio=1.55; Table 4). Accordingly,
the obesity alleles of the common obesity-associated SNPs outside
of the MC4R coding region (rs12970134 and rs1943229) were less
frequently transmitted to obese offspring in the presence of the
weight-lowering variants of the two MC4R polymorphisms
(Val103Ile and Ile251Leu; Table 3; left panel) as indicated by
transmission-ratios below 1. Subsequently, we removed the
heterozygous carriers (total n=108) at Val103Ile (n=85) and
Ile251Leu (n=23) from the full sample to explore their impact on
the TDT findings for the two distant SNPs (rs12970134,
Figure 1. Genomic region encompassing the melanocortin 4 receptor gene (MC4R; location indicated by the vertical bar). Displayed
are results of transmission disequilibrium tests of single markers and selected two-marker haplotypes in the detection sample of 424 obesity trios
(two-sided exact p-values). The black dots indicate single marker TDT results for all 78 SNPs whereas the dots surrounded by a circle highlight the 8
SNPs used for two-marker haplotype construction (selected based on conditional analyses). The region covered by each two-marker haplotype
combination is displayed as a line (only those haplotypes with a p-value#0.1 and whose p-value was below the p-value of each single-marker test are
displayed). Surrounding double circles indicate those SNPs (single-marker TDT) of the best supported haplotype result; Haplo 3 spans MC4R.I n
addition, grey lines indicate recombination rates according to HAPMAP CEU.
doi:10.1371/journal.pone.0013967.g001
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rs12970134 and the risk haplotype of Haplo 3 associated to obesity
(TDT p-value=0.02 after Bonferroni correction for the 78 tests
performed) increased slightly (A allele: RR 1.33 to 1.35; [A; G]
allele: hRR 1.61 to 1.64) the point estimate for the other distant
SNP rs1943229 did not change (uncorrected TDT p-value=0.86;
G allele: RR 1.03). Similarly, joint modelling of the effects of the
two distant SNPs and the non-synonymous MC4R polymorphisms
collapsed into one covariate [20] resulted in hardly any change of
the obesity effects of the two distant SNPs (Table 5; left panel;
rs12970134, A allele: RR 1.45 to 1.43; rs1943229, G allele: RR
1.23 to 1.24), while the effect for the collapsed wild-type alleles of
the two non-synonymous MC4R polymorphisms was slightly
reduced (RR 1.66 to 1.54 [20]).
In a subgroup (n=525, see [12,21]) of the 787 trios we also
analyzed if mutations in the MC4R coding region that lead to a
reduced receptor function can in part explain the effect observed for
the common obesity-associated SNPs outside of the MC4R coding
region. We had previously screened the MC4R coding region for
mutations (dHPLC [21]). We observed heterozygous carriers of the
following MC4R mutations that lead to a reduced receptor function
as shown by at least one functional assay: Ser30Phe [9], [Tyr35-
Stop; 110A.T] [9], Pro78Leu [22], Ser94Arg [21,23], Thr112Met
[24], Ile121Thr [21,23], Ser127Leu [9,21], Arg165Trp [24,25],
Ala175Thr [26], Gly181Asp [21,23,27], Ala244Glu [21], deletion
of 4 base pairs at codon 211 (L211fsX216 [21,26]; Ile317Thr [24].
For one mutation (Met200Val), two functional assays (cAMP
response and cell surface expression) revealed a function similar to
the wild-type MC4R [9,28]. However, for some of the other
mutations, there was only one amongst a variety of assays that
showed a deviation from the wild-type receptor (e.g. Thr112Met;
wild-type function in [9,21,23]; only Nijenhuis et al. [24] described
Table 1. Global transmission disequilibrium tests (HAP-TDT) of all three best two-marker haplotype combinations (according to p-
values) in the genomic region covering the melanocortin 4 receptor gene (MC4R) in 424 obesity trios of the detection sample, the
confirmation sample of 363 obesity trios and in the joint sample of 787 obesity trios.
1
st SNP of
two-marker
haplotype
chrom.18
physical
position in
base pairs
a
2
nd SNP of
two-marker
haplotype
chrom.18
physical position
in base pairs
a
detection
sample (424
obesity trios)
p-value
b
confirmation
sample (363
obesity trios)
p-value
b
joint sample
(787 obesity
trios)
p-value
b
joint sample (787
obesity trios) hRR
c for
obesity risk
haplotype [95% CI]
Haplo 1 rs17700028 55,926,664 rs12970134 56,035,730 5.2610
24 0.039 5.7610
24 3.24 [0.36–29.12]
Haplo 2 rs12970134 56,035,730 rs1943226 56,186,184 5.2610
24 0.093 6.0610
25 1.48 [1.23–1.78]
Haplo 3 rs12970134 56,035,730 rs1943229 56,237,438 0.001 0.074 1.7610
24 1.61 [1.30–2.00]
abase pair position on chromosome 18 according to http://www.ncbi.nlm.nih.gov (hg18);
bpermutation-based p-value based on 10
6 simulations;
chaplotypic relative risk (hRR) relative to the most frequent haplotype for the haplotype comprising the two obesity risk alleles of the 1
st and 2
nd SNP with 95%
confidence intervals (95% CI).
doi:10.1371/journal.pone.0013967.t001
Table 2. Single-marker transmission disequilibrium tests in the detection sample (424 obesity trios), the confirmation sample (363
obesity trios) and in the joint sample (787 obesity trios).
SNP
chrom.18
physical
position in
base pairs
a
obesity
effect /
other
allele sample
EAF
b in
parents
[%]
obesity allele
transmissions
other allele
transmissions
relative risk for
effect allele
(95% CI
c)
two-sided
exact p-
value TDT
d
rs17700028 55,926,664 [G; A] detection 8.08 75 56 1.34 (0.95–1.89) 0.120
[A; G] confirmation 90.48 73 50 1.47 (1.02–2.12) 0.047
[A; G] joint 91.26 129 125 1.03 (0.81–1.32) 1.000
rs12970134 56,035,730 [A; G] detection 30.54 205 150 1.37 (1.11–1.69) 0.004
[A; G] confirmation 27.55 169 131 1.29 (1.03–1.62) 0.045
[A; G] joint 29.15 374 281 1.33 (1.14–1.55) 2.5610
24
rs1943226 56,186,184 [T; G] detection 89.51 82 77 1.06 (0.69–1.28) 0.750
[G; T] confirmation 10.34 65 62 1.05 (0.74–1.49) 0.630
[T; G] joint 89.58 144 142 1.01 (0.81–1.28) 0.860
rs1943229 56,035,730 [G; T] detection 79.91 141 136 1.04 (0.82–1.31) 0.680
[G; T] confirmation 80.72 112 110 1.02 (0.78–1.32) 1.000
[G; T] joint 80.28 253 246 1.03 (0.86–1.23) 0.860
abase pair position on chromosome 18 according to http://www.ncbi.nlm.nih.gov (hg18);
bobesity effect allele frequency;
cconfidence interval;
dp-values were calculated using PLINKs9 adaptive permutation procedure with 10
6 permutations.
Displayed are the SNPs included in the three best haplotypes (Table 1) for the explored genomic region surrounding the melanocortin 4 receptor gene (MC4R, location:
chromosome 18: 55,879,013–56,243,921 bps). The obesity-predisposing allele (obesity effect allele) within each sample is highlighted in bold.
doi:10.1371/journal.pone.0013967.t002
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Met200Val asa functionallyrelevant mutation;ratingasa wild-type
receptor did not alter the results (data not shown).
Again, removal of the mutation carriers from the analysis did not
alter the results for the distant SNPs or the two-marker haplotype
strongly (rs12970134-A: RR 1.38 to 1.34; rs1943229-G: RR 1.05 to
1.03; hRR for [A; G] of Haplo 3: 1.82 to 1.70). For the more distant
marker rs12970134 and for the obesity effect haplotype [A; G] of
Haplo 3, the effect was slightly reduced in comparison to the model
of not removing the mutation carriers. For rs1943229 located closer
to the coding region of the MC4R the association signal remained
nearly the same upon removal of the mutation carriers. Similar
observations were made for the joint modelling of the distant SNPs,
the non-synonymous MC4R polymorphisms and the mutations
(Table5;rightpanel).Forthejointmodelling,wecollapsedthe wild-
type alleles of the non-synonymous MC4R polymorphisms into one
covariate and all mutations into another [20] as each single MC4R
mutation is almost a private event. Here, in contrast to the
observation for the non-synonymous MC4R polymorphisms
Val103Ile and Ile251Leu, the combination of all functional
mutations (n=15) resulted in an additional independent obesity-
association signal for the mutations (p-values#0.05 in model 2
analyzing the mutations only and model 3 joint modelling of distant
SNPs, the non-synonymous MC4R polymorphisms and the
mutations; Table 5 right panel) which was even strengthened (RR
2.57 to 2.91) upon inclusion of the polymorphisms.
Discussion
At the MC4R locus, common SNPs are associated with
polygenic forms of obesity and variants leading to a reduced
MC4R function entail a major gene effect for obesity. Thus this
gene locus is ideally suited for the analysis of synthetic association.
We performed conditional as well as haplotype analyses for a
genomic region approximately 310 kb downstream of the MC4R
to 53 kb upstream of the MC4R coding region (between two
recombination hotspots). In contrast to prior analyses [1], we had
the advantage of being able to use directly genotyped data from
nuclear families. Thus, we did not have to rely on imputed
genotypes; estimation of haplotypes is simplified and transmission
patterns can be explored.
Haplotype analyses are known to be more powerful than single-
marker analyses for the detection of a genomic region that is
enriched for phenotype-relevant mutation(s)/causal variant(s).
Recently, the analysis of WTCCC (Wellcome Trust Case Control
Consortium) data sets of seven complex disorders suggested that
haplotype analyses in current GWAS can guide future re-
sequencing approaches to identify underlying rare functional
variants [29]. Therefore, we analyzed haplotypes flanking the
MC4R. We observed a stronger association signal upon combining
the information of SNPs from the 39 and 59 regions than for each
single SNP in two independent TDT-based association studies.
Whether the constructed obesity haplotype points to an ancestral
obesity haplotype or if it reflects the impact of two relatively
independent loci in the vicinity of the MC4R is beyond the scope of
our analyses. However, as we have limited our analysis to the
region between the recombination hotspots derived from 30 CEU
Hapmap trios [1] 39 and 59 to the MC4R we attempted to increase
the chance to detect an ancestral haplotype.
As we identified a relatively common risk haplotype (frequency
of [A; G] of Haplo 3 equals to 15.7% in the 787 parents) covering
the MC4R coding region, we also analyzed if the associations of
Table 3. MC4R coding variants and their relationship to haplotype frequencies and transmission ratios of the two-marker
haplotype comprising the SNPs rs12970134 (39end) and rs1943229 (59end) in the MC4R region.
MC4R
coding
region
haplotype
[rs12970134;
rs1943229]
(obesity effect
allele)
a
non-synonymous MC4R polymorphisms (Val103Ile and
Ile251Leu) whose major (wild-type) alleles are
associated with obesity (787 obesity trios)
b
functionally relevant obesity MC4R mutations (525
obesity trios)
c
expected
frequency in
parents under
indepen-dence
[%]
estimated
frequency
in parents
[%]
trans-
mitted
d
non-
trans-
mitted
d
trans-
missionratio
e
expected
frequency in
parents
under
indepen-
dence [%]
estimated
frequency
in parents
[%]
trans-
mitted
d
non-
trans-
mitted
d
trans-
missionratio
e
MC4R wild-
type
[G; G] 61.3 62.2 346.0 412.1 0.84 62.5 64.0 224.2 286.5 0.78
[A; G] 14.9 15.6 246.0 158.0 1.56 15.6 15.5 168.6 103.9 1.62
[A; T] 12.7 13.4 177.8 172.8 1.03 13.1 13.2 118.2 122.1 0.97
[G; T] 6.0 3.3 89.2 98.2 0.91 6.5 6.3 61.0 70.5 0.87
presence of
any MC4R
variation
a
[G; G] 3.2 2.4 27.82 43.76 0.64 1.5 0.5 7.6 5.6 1.36
[A; G] 0.8 0.1 1.18 2.22 0.53 0.4 0.2 5.6 0 -
[A; T] 0.7 0 - - - 0.3 0.2 3.7 0 -
[G; T] 0.3 0.03 0.002 1.02 0.002 0.2 0.1 1.1 1.4 0.8
anote that the minor alleles of the two non-synonymous polymorphisms (Val103Ile and Ile251Leu; left panel) are negatively associated with obesity whereas the
functionally relevant mutations (right) are all obesity-related;
bhere, all 787 obesity trios were incorporated in the haplotype estimation;
chere, a subset of 525 obesity trios for which information on functionally relevant obesity MC4R mutations was available and incorporated in the haplotype estimation;
ddecimals in transmitted and non-transmitted haplotypes result from haplotype estimations;
etransmission ratios were obtained from FAMHAP (version 18).
doi:10.1371/journal.pone.0013967.t003
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synthetic association [18,19]. Synthetic association implies that
GWAS signals of common non-functional SNPs outside of coding
regions may be the result of a combination of rare coding/
functional variants with stronger effects. This is in contrast to the
more widespread idea that association signals of common non-
functional SNPs outside of coding regions point to a common
causal variant.
To further explore this idea, we analyzed the influence of coding
variants (two coding polymorphisms and several functionally
relevant rare mutations) in MC4R on the transmission of the
obesity effect haplotype as well as on the obesity effect alleles of the
two SNPs at the 39 and 59 ends forming the obesity effect
haplotype. Both the removal of individuals with MC4R coding
variants and the inclusion of the information on MC4R coding
variant status in a regression model had basically no impact on the
estimators of the obesity effect alleles of two SNPs at the 39 and 59
ends of the MC4R, as well as for the obesity effect haplotype. This
observation did not support the model of synthetic association [18]
for the MC4R coding region. Thus, we conclude that the
investigated genetic variation within the coding region cannot
explain the obesity association effect of the 39 SNP rs12970134 or
that of its haplotype combinations with rs12970134 (Haplo 3)
observed in our samples. However, we cannot exclude that other
functional variants [30–32] outside of the coding region of the
MC4R contribute to the GWAS obesity association signal.
Moreover, we cannot exclude that other less frequent non-coding
variants not properly tagged by the current GWAS technology
may be correlated to the MC4R coding variants. Finally, our
analyses are based on a relatively small sample size, which results
in low power to detect potentially small synthetic association
effects.
In sum, we detected a haplotype covering the MC4R coding
region; or at least a secondary independent signal 59 of the MC4R
which is associated with extreme obesity. Recently, a meta-analysis
comprising GWASdataof123,865 individualsofEuropeanancestry
followed by confirmatory analyses in up to 125,931 independent
individuals also described a secondary independent signal at the
MC4R locus at a position similar to the one we detected [33].
We observed a stronger association signal for an obesity effect
haplotype as compared to single-marker signals in both our
detection and our confirmatory samples. Accounting for genetic
variation in the MC4R coding region following the idea of
synthetic association had hardly any impact on the association
signal in our sample. Consequently, the genomic region of Haplo 3
(201,708 base pairs) could be a focus of a deep sequencing
approach aiming at the detection of additional obesity mutations/
polymorphisms outside of the MC4R coding region. We aim at re-
sequencing this region in the extremely obese individuals
harbouring the risk haplotype ([A; G] of Haplo 3); subsequently
we will analyze [34] newly identified potentially causal rare
variants in independent well-powered case-control samples.
Materials and Methods
Study group
A total of 787 obesity trios comprising an extremely obese child
or adolescent (index patients, see [35]) and both of their biological
Table 4. Analyses for the two-marker haplotype comprising the SNPs rs12970134 (39end) and rs1943229 (59end) in the MC4R
region.
haplotype [rs12970134;
rs1943229] (obesity effect allele) sample
frequency in
parents [%] transmitted
a
non-
transmitted
a
transmission
ratio
b
hRR
c
(95% CI
d)
nominal
two-sided p-
value (hRR
c)
detection 62.8 173.6 229.0 0.76 ref –
[G; G] confirmation 66.5 154.9 181.4 0.85 ref –
joint 64.7 328.6 410.7 0.80 ref –
detection 17.1 146.4 88.0 1.66 1.70
(1.28–2.25)
2.8610
24
[A; G] confirmation 14.2 99.1 70.6 1.40 1.49
(1.08–2.06)
0.016
joint 15.7 245.4 158.3 1.55 1.61
(1.30–2.00)
1.3610
25
detection 13.3 94.6 99.0 0.96 1.02
(0.74–1.42)
0.89
[A: T] confirmation 13.4 82.9 73.4 1.13 1.04
(0.74–1.46)
0.82
joint 13.4 177.6 172.7 1.03 1.03
(0.82–1.30)
0.81
detection 6.7 52.4 51.0 1.03 1.18
(0.78–1.80)
0.43
[G; T] confirmation 5.9 37.1 48.6 0.76 0.84
(0.76–1.86)
0.45
joint 6.3 89.4 99.3 0.90 1.01
(0.74–1.37)
0.95
adecimals in transmitted and non-transmitted haplotypes result from haplotype estimation;
btransmission ratios were obtained from FAMHAP (version 18);
chaplotypic relative risks calculated by conditional logistic regression using the R-package ‘‘DGCgenetics’’ (additive haplotypic model);
dconfidence interval.
doi:10.1371/journal.pone.0013967.t004
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consent was given by all participants and in case of minors by their
parents. The study was approved by the Ethics Committees of the
Universities of Marburg and Essen and conducted in accordance
with the guidelines of The Declaration of Helsinki.
Genotyping
Genotyping in 424 obesity trios was performed on the Genome-
Wide Human SNP Array 6.0 (http://www.affymetrix.com) by
ATLAS Biolabs GmbH (Berlin, Germany). Birdseed V-2 algo-
rithm was applied for calling. For genotyping of rs12970134 and
rs1943229 we used available TaqMan assays (C___3058722_10
and C__11962333_10, Applied Biosystems, Germany). The
variants rs17700028 and rs1943226 were genotyped using
ARMS-PCR [36], primers are available upon request. The non-
synonymous MC4R polymorphisms Val103Ile (rs2229616 – also
available on the Genome-Wide Human SNP Array 6.0) and
Ile251Leu (rs52820871) were genotyped as described previously
[22]. To validate the genotypes, allele determination was made
independently by at least two experienced individuals. Discrepan-
cies were solved unambiguously either by reaching consensus or by
repeating.
Table 6. Description of the investigated two independent German family-based data sets (detection and confirmation sample).
Study group status n total (female)
age [years]
(mean; SD)
BMI [m/kg
2]
(mean; SD)
BMI Z-score
(mean; SD)
a
detection: obesity trio genome-
wide association study
extremely obese children and
adolescents
index patients 424 (224) 13.20 (2.80) 31.93 (5.39) 4.22 (1.84)
parents of the obese children
and adolescents
parents 848 (424) 42.32 (6.07) 30.40 (6.44) 1.66 (1.85)
confirmation: obesity trios
genotyped for four SNPs
extremely obese children and
adolescents
index patients 363 (209) 13.38 (3.40) 32.46 (6.45) 4.35 (2.15)
parents of the obese children
and adolescents
parents 726 (363) 40.62 (5.92) 30.42 (6.15) 1.72 (1.81)
a[33].
doi:10.1371/journal.pone.0013967.t006
Table 5. Conditional logistic regression analysis including effects of the two-marker haplotype SNPs (rs12970134, rs1943229), the
two coding polymorphisms (weight lowering effect: Val103Ile, Ile251Leu) and any other functionally relevant obesity MC4R
mutations.
regression
model
a
non-synonymous MC4R polymorphisms (Val103Ile and
Ile251Leu) whose major (wild-type) alleles are
associated with obesity
b (787 obesity trios)
functionally relevant obesity MC4R mutations
c (525
obesity trios)
obesity effect
allele
RR for
effect
allele
95% CI for RR
for effect
allele p-value
obesity effect
allele
RR for
effect
allele
95% CI for RR
for effect
allele p-value
model 1 rs12970134 A 1.45 1.21–1.73 4.5610
25 A 1.55 1.24–1.92 8.9610
25
rs1943229 G 1.23 1.01–1.52 0.042 G 1.32 1.04–1.68 0.024
model 2 MC4R coding
region variant
collapsed Val103Ile
and Ile251Leu
wild-type allele
1.66 1.04–2.63 0.032 collapsed Val103Ile
and Ile251Leu
wild-type allele
1.48 0.85–2.57 0.170
collapsed functionally
relevant obesity
mutations
c
mutated allele
2.57 1.07–6.15 0.034
model 3 rs12970134 A 1.43 1.20–1.71 7.9610
25 A 1.52 1.22–1.90 1.8610
24
rs1943229 G 1.24 1.01–1.51 0.042 G 1.30 1.02–1.65 0.037
MC4R coding
region variant
collapsed Val103Ile
and Ile251Leu
wild-type allele
1.54 0.96–2.48 0.073 collapsed Val103Ile
and Ile251Leu
wild-type allele
1.37 0.77–2.45 0.290
collapsed functionally
relevant obesity
mutations
c
mutated allele
2.91 1.05–8.09 0.041
amodel 1 included rs12970134, rs1943229 whereas model 2 included either the non-synonymous MC4R polymorphisms (Val103Ile and Ile251Leu) (left and right panel) or the
functionally relevant obesity MC4R mutations (right panel) as one explanatory variables; in model 3, both rs12970134, rs1943229 and the coding variants were included;
bwild-type alleles at the non-synonymous MC4R polymorphisms (Val103Ile and Ile251Leu) were combined into one covariable; c mutation alleles Ser30Phe, [Tyr35Stop;
110A.T], Pro78Leu, Ser94Arg, Thr112Met, Ile121Thr, Ser127Leu, Arg165Trp, Ala175Thr, Gly181Asp, Met200Val, Ala244Glu, L211fsX216, Ile317Thr were combined into
one covariable; the 525 obesity trios are a subset of all 787 trios for which information on functionally relevant obesity MC4R mutations were available.
doi:10.1371/journal.pone.0013967.t005
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For the functionally relevant obesity MC4R mutations, we used
the previously published mutation screen data (525 trios) [21].
Statistical analyses
For the GWAS data on 424 obesity trios, SNPs with a call rate
,95%, departure from Hardy-Weinberg equilibrium in the
parents (two-sided exact test ,0.001), or with minor allele
frequency below 1 percent in the parents were excluded from the
analysis (20 SNPs in the 6200 kb region as described below). In
addition, all SNPs were set to ‘‘missing’’ in case of Mendelian
inconsistent calls within a family. From the genome-wide data
set, 78 SNPs were selected that met the quality control criteria
and which were within a genomic region defined as 200 kb 39 of
the most distant previously reported GWAS SNP (rs17782313)
[1] to 200 kb 59 of the MC4R coding region. On this marker set,
we performed single-marker transmission disequilibrium tests
(TDTs) [37] using PLINK v1.07. Relative Risks were estimated
by use of conditional logistic regression. Subsequently, we aimed
to screen for a set of SNPs which most likely contributed
secondary independent association signals. We performed
conditional analyses on the SNP (rs12970134) with the strongest
primary signal using FAMHAP (version 18) [38]. This test is
based on the idea that transmission of haplotypes of closely
linked SNPs involving rs12970134 would not depend on allelic
status at another SNP, if rs12970134 is the only causal variant.
For screening purposes, we selected those SNPs with a
permutation-based p-value below 0.05 in the conditional test.
Afterwards, we performed family-based association tests of all
two-marker haplotypes for the set of selected SNPs (primary and
secondary signals) using the weighted haplotype test as provided
in FAMHAP (HAP-TDT) [38]. Again, permutation-based p-
values were derived. In addition, to overcome the problem of
h a p l o t y p ep h a s i n gi nt h ep o s s i b l ep r e s e n c eo fs o m er e c o m b i n a -
tions, we estimated effect sizes such as relative risks with
conditional logistic regression under a log-additive mode of
inheritance applying the R-package ‘DGCgenetics’ provided by
David Clayton. To address the inherent multiplicity and over-
fitting problem in the GWAS detection sample, we limited the
analyses in the independent confirmation sample (363 obesity
case-parents trios) to those models including the two SNPs of
Haplo 3 (rs12970134, rs1943229). Using the observed data from
the detection data set and simplified adapting it to the bi-allelic
case to derive a power estimate for the confirmatory sample
using Quanto 1.2.4, we estimated that 363 trios would have
a power of 97% to detect an RR effect of RR=1.7 under a
log-additive mode of inheritance (minor allele frequency 15%,
atwo-sided=0.05).
Finally, we jointly analyzed all 787 trios. For the exploration of
the genomic region in order to support the idea of ‘synthetic
association’, we phased our data sets using FAMHAP (version 18)
[38]. Additionally, we applied conditional logistic regression
analyses as implemented in R v.2.9.0 incorporating the SNPs
rs12970134, and rs1943229 as well as the variants in the MC4R
coding region as independent covariants hierarchically. To enable
estimation, we adopted the idea of Li and Leal [20] and collapsed
effects of similar variant classes (non-synonymous MC4R poly-
morphisms or functionally relevant obesity MC4R mutations).
Linkage disequilibrium measurements for the polymorphisms
rs12970134, rs1943229, Val103Ile (rs2229616) and Ile251Leu
(rs52820871) were based on haplotype phasing incorporating all
four variants.
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